A LIGHT ON THE EFFECT OF POMEGRANATE ON NEUROLOGICAL EVIDENCES OF PARKINSON’S DISEASE: A REVIEW

PDF

Published: 2020-04-06

Page: 47-58


SWAPNALI CHETIA *

Department of Zoology, Rajiv Gandhi University, Rono Hills, Doimukh – 791112, Arunachal Pradesh, India.

GAURAB BORAH

Department of Zoology, Rajiv Gandhi University, Rono Hills, Doimukh – 791112, Arunachal Pradesh, India.

*Author to whom correspondence should be addressed.


Abstract

Parkinson’s disease (PD) is a progressive neurodegenerative disease, in which the dopamine containing neurons gets degenerated in the SN region of ventral mid-brain. Various herbal or plant components have been tested in rodent models of Parkinson’s disease to understand its therapeutic effect. Recent progresses in therapeutic interventions against neurodegenerative disorders have shown the potential role of Pomegranate juice (PJ) as a promising neuroprotective agent. The fruit of pomegranate is a highly consumed all over the world and has proven its efficacy in many health beneficial aspects. PJ contains active ingredients mainly, ‘polyphenols’ which are found to be protective against the disease pathology of Alzheimer’s disease. A recent study demonstrated that PJ potentiate parkinsonian pathology in rodent. Meanwhile, PJ had shown neuroprotective effect in parkinsonian toxin induced cellular model. Thus, from the available literatures, no conclusion can be made whether PJ possess neuroprotective or neurodegenerative potential towards dopamine containing neurons in PD.As pomegranate juice has been recommended to possess medical benefit and is being used in daily diet, studying its potential benefits or side effect are of immense importance. Amending altogether, the therapeutic potency of pomegranate has been well evaluated and reported and the review had been forwarded to evaluate the diversified effects of pomegranate juice in Parkinson's disease.

Keywords: Parkinson’s disease, neurodegeneration, neuroprotection, pomegranate, phytocomponents.


How to Cite

CHETIA, S., & BORAH, G. (2020). A LIGHT ON THE EFFECT OF POMEGRANATE ON NEUROLOGICAL EVIDENCES OF PARKINSON’S DISEASE: A REVIEW. UTTAR PRADESH JOURNAL OF ZOOLOGY, 41(2), 47–58. Retrieved from https://mbimph.com/index.php/UPJOZ/article/view/1488

Downloads

Download data is not yet available.

References

Braidy N, Selvaraju S, Essa MM, Vaishnav R, Al-adawi S, Al-asmi A, Al-senawi H, Abd A, Alobaidy A, Lakhtakia R, Guillemin GJ. Neuroprotective effects of a variety of pomegranate juice extracts against MPTP-Induced Cytotoxicity and Oxidative Stress in Human Primary Neurons. OxidativeMedicine Cell. Longev. 2013;685909.

Choi JG, Kim HG,, Kim MC, Yang WM, Huh Y, Kim SY, Oh MS. Polygalae radix inhibits toxin-induced neuronal death in the Parkinson's disease models. Journal of Ethno-pharmacology. 2011;134(2): 414-421.

Hartman RE, Shah A, Fagan AM, Schwetye KE, Parsadanian M, Schulman RN, Finn MB, Holtzman DM. Pomegranate juice decreases amyloid load and improves behavior in a mouse model of Alzheimer's disease. Neurobiol Dis. 2006;24(3):506–515.

Rojanathammanee L, Puig KL, Combs CK. Pomegranate polyphenols and extract inhibit nuclear factor of activated T-cell activity and microglial activation in vitro and in a transgenic mouse model of Alzheimer disease. J. Nutr. 2013;143(5):597–605.

Tapias V, Cannon JR, Greenamyre JT. Pomegranate juice exacerbates oxidative stress and nigrostriatal degeneration in Parkinson's disease. Neurobiology of Ageing. 2014;35 (5):1162-1176.

Frautschy SA, Horn DL, Sigel JJ, Harris-White ME, Mendoza JJ, Yang F, Saido TC, Cole GM. Protease inhibitor coinfusion with amyloid beta-protein results in enhanced deposition and toxicity in rat brain. J. Neurosci. 1998;18(20): 8311–8321.

Colombo E, Sangiovanni E, Dell’agli M. A review on the anti-inflammatory activity of pomegranate in the gastrointestinal tract. Evid. Based. Complement. Alternat. Med. 2013; 247145.

Díaz-pérez JC, Jukic M, Goreta S, Gadz J, Maclean D. Physical and chemical properties of pomegranate fruit accessions from Croatia. Food Chem. 2015;177:53–60.

Faria A, Calhau C.The bioactivity of pomegranate: Impact on health and disease. Crit. Rev. Food Sci. Nutr. 2011;51(7):626–634.

Gil MI, Tomas-Barberan FA, Hess-Pierce B, Holcroft DM, Kader AA. Antioxidant activity of pome granate juice and its relationship with phenolic composition and processing. J. Agric. Food Chem. 2000;48(10):4581–4589.

Liberatore G, Jackson-Lewis V, Vukosavic S, Mandir AS, Vila M, McAuliffe WG, Dawson VL, Dawson TM, Przedborski S. Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease. Nature Medicine. 1999;5 (12):1403–1409.

Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci U S A. 1990; 87(4):1620–1624.

Auerbach L, Rakus J, Bauer C, Gerner C, Ullmann R, Wimmer H, Huber J. Pomegranate seed oil in women with menopausal symptoms: a prospective randomized, placebo-controlled, double-blinded trial. Menopause (New York, N.Y.). 2012;19(4):426–432.

Farhangi H, Ajilian M, Saeidi M, Khodaei GH. Medicinal fruits in Holy Quran. Indian J. Pediatr. 2014;2(3-2):89–102.

Guo C, Yang J, Wei J, Li Y, Xu J, Jiang Y. Antioxidant activities of peel, pulp and seed fractions of common fruits as determined by FRAP assay. Nutr. Res. 2003;23(12):1719–1726.

July VI, Venkata C, Prakash S, Prakash I. Bioactive chemical constituents from pomegranate (Punica granatum) juice, seed and peel: A review. Int. J. Res. Chem. Environ. 2011;1(1):1–18.

Mizrahi M, Levi YF, Larush L, Frid K, Binyamin O, Dori D, Fainstein N, Ovadia H, Hur TB,Magdassi S, Gabizon R. Pomegranate seed oil nanoemulsions for the prevention and treatment of neurodegenerative diseases: the case of genetic CJD. Nanomedicine: Nanotechnology, BiologyandMedicine. 2014; 10(6):1353-1363.

Çam M, Hişil Y. Pressurised water extraction of polyphenols from pomegranate peels. Food Chem. 2010;123(3):878–885.

Ismail T, Sestili P, Akhtar S. Pomegranate peel and fruit extracts: A review of potential anti-inflammatory and anti-infective effects. J. Ethnopharmacol. 2012;143(2):397–405.

Ono NN, Bandaranayake PCG, Tian L. Establishment of pomegranate (Punica granatum) hairy root cultures for genetic interrogation of the hydrolyzable tannin biosynthetic pathway. Planta. 2012;236:931–941.

Ono NN, Britton MT, Fass JN, Nicolet CM, Lin D, Tian L. Exploring the transcriptome landscape of pomegranate fruit peel for natural product biosynthetic gene and SSR marker discovery. J. Integr. Plant Biol. 2011;53(10): 800-13.

Kasimsetty SG, Bialonska D, Reddy MK, Ma G, Khan SI, Ferreira D. Colon cancer chemopreventive activities of pomegranate ellagitannins and urolithins. J. Agric. Food Chem. 2010;58(4):2180–2187.

Newman RA, Lansky EP, Block ML. Pomegranate: The most medicinal fruit. Basic Health Publications. A Wealth of Phytochemicals; 2007.

[ISBN: 9781591205357]

Khan N, Hadi N, Afaq F, Syed DN, Kweon MH, Mukhtar H. Pomegranate fruit extract inhibits prosurvival pathways in human A549 lung carcinoma cells and tumor growth in athymic nude mice. Carcinogenesis. 2007;28 (1):163–73.

Aggarwal BB, Shishodia S. Molecular targets of dietary agents for prevention and therapy of cancer. Biochem. Pharmacol. 2006;71:1397–1421.

Chrubasik-Hausmann S, Vlachojannis C, Zimmermann B. Pomegranate juice and prostate cancer: Importance of the characterisation of the active principle. Phytother. Res. 2014;28(11):1676–1678.

Kim ND, Mehta R, Yu W, Neeman I, Livney T, Amichay A, Poirier D, Nicholls P, Kirby A, Jiang W, Mansel R, Ramachandran C, Rabi T, Kaplan B, Lansky E. Chemopreventive and adjuvant therapeutic potential of pomegranate (Punica granatum) for human breast cancer. Breast Cancer Res Treat. 2002;71(3): 203–17.

Lansky EP, Newman RA.Punica granatum (pomegranate) and its potential for prevention and treatment of inflammation and cancer. J. Ethnopharmacol. 2007;109(2):177–206.

Li Y, Guo C, Yang J, Wei J, Xu J, Cheng S. Evaluation of antioxidant properties of pomegranate peel extract in comparison with pomegranate pulp extract. Food Chem. 2006; 96(2):254–260.

Alighourchi H, Barzegar M. Some physicochemical characteristics and degradation kinetic of anthocyanin of reconstituted pomegranate juice during storage. J. Food Eng. 2009;90:179–185.

Alighourchi H, Barzegar M, Abbasi S. Anthocyanins characterization of 15 Iranian pomegranate (Punica granatum L.) varieties and their variation after cold storage and pasteurization. Eur. Food Res. Technol. 2008;227:881–887.

Alighourchi H, Barzegar M, Abbasi S. Effect of gamma irradiation on the stability of anthocyanins and shelf-life of various pomegranate juices. Food Chem. 2008;110: 1036–1040.

Mena P, Calani L, Dall’Asta C, Galaverna G, Garcia-Viguera C, Bruni R, Crozier A, Del Rio D.Rapid and comprehensive evaluation of (poly)phenolic compounds in pomegranate (Punica granatum L.) juice by UHPLC-MSn. Molecules. 2012;17(12):14821–14840.

Milbury PE, Kalt W. Xenobiotic metabolism and berry flavonoid transport across the blood? Brain barrier. J. Agric. Food Chem. 2010;58 (7):3950–3956.

Gozlekci S, Saracoglu O, Onursal E, Ozgen M. Total phenolic distribution of juice, peel and seed extracts of four pomegranate cultivars. Pharmacogn. Mag. 2011;7(26):161–164.

Mirdehghan SH, Rahemi M, Serrano M, Guillen F, Martinez-Romero D, Valero D. Prestorage heat treatment to maintain nutritive and functional properties during postharvest cold storage of pomegranate. J. Agric. Food Chem. 2006;54(22):8495–8500.

Adams LS, Seeram NP, Aggarwal BB, Takada Y, Sand D, Heber D. Pomegranate juice, total pomegranate ellagitannins, and punicalagin suppress inflammatory cell signaling in colon cancer cells. J. Agric. Food Chem. 2006;54: 980–985.

Aviram M, Dornfeld L, Rosenblat M, Volkova N, Kaplan M, Coleman R, Hayek T, Presser D, Fuhrman B. Pomegranate juice consumption reduces oxidative stress, atherogenic modifications to LDL and platelet aggregation: studies in humans and in atherosclerotic apolipoprotein E-deficient mice. Am. J. Clin. Nutr. 2001;71(5):1062–1076.

Basu A, Penugonda K. Pomegranate juice: a heart-healthy fruit juice. Nutr. Rev. 2009;67 (1):49–56.

Clifford MN, Scalbert A. Review Ellagitannins – nature, occurrence and dietary burden. J. Sci. Food Agric. 2000;80(7):1118–1125.

Dkhil MA. Anti-coccidial, anthelmintic and antioxidant activities of pomegranate (Punica granatum) peel extract. Parasitol. Res. 2013; 112(7):2639–2646.

Heber D. Multitargeted therapy of cancer by ellagitannins. Cancer Lett. 2008;269(2):262–268.

Larrosa M, García-Conesa MT, Espín JC, Tomás-Barberán FA. Ellagitannins, ellagic acid and vascular health. Mol. Aspects Med. 2010; 31(6):513-39.

Panichayupakaranant P, Itsuriya A, Sirikatitham A. Preparation method and stability of ellagic acid-rich pomegranate fruit peel extract. Pharm. Biol. 2010;48(2):201–205.

Aslam MN, Lansky EP, Varani J. Pomegranate as a cosmeceutical source: pomegranate fractions promote proliferation and procollagen synthesis and inhibit matrix metalloproteinase-1 production in human skin cells. J. Ethnopharmacol. 2006;103:311–318.

Bialonska D, Kasimsetty SG, Schrader KK, Ferreira D. The effect of pomegranate (Punica granatum L.) byproducts and ellagitannins on the growth of human gut bacteria. J. Agric. Food Chem. 2009;57(18):8344–8349.

Kish SJ, Morito C, Hornykiewicz O. Glutathione peroxidase activity in Parkinson's disease brain. Neuroscience Letters. 1985;58 (3):343-346.

Most D, Kozlow J, Heller J, Shermak MA. Thromboembolism in plastic surgery. Plastic and Reconstructive Surgery. 2005;115(2):20e-30e.

Ascacio-valdés JA, Buenrostro-figueroa JJ, Aguilera-carbo A. Ellagitannins: Biosynthesis, biodegradation and biological properties. J. Med. Plants Res. 2011;5:4696–4703.

Knott C, Stern G, Wilkin GP. Inflammatory regulators in Parkinson's disease: iNOS, lipocortin-1 and cyclooxygenases-1 and-2. Mol Cell Neurosci. 2000;16(6):724–739.

Filannino P, Azzi L, Cavoski I, Vincentini O, Rizzello CG, Gobbetti M, Di Cagno R. Exploitation of the health-promoting and sensory properties of organic pomegranate (Punica granatum L.) juice through lactic acid fermentation. Int. J. Food Microbiol. 2013;163 (2-3):184–192.

Fuhrman B, Volkova N, Aviram M. Pomegranate juice inhibits oxidized LDL uptake and cholesterol biosynthesis in macrophages. J. Nutr. Biochem. 2005;16(9): 570–576.

Nagata M, Hidaka M, Sekiya H, Kawano Y, Yamasaki K., Okumura M, Arimori K. Effects of pomegranate juice on human cytochrome P450 2C9 and tolbutamide pharmacokinetics in rats. Drug Metab. Dispos. 2007;35(2):302–305.

Fawole OA, Makunga NP, Opara UL. Antibacterial, antioxidant and tyrosinase-inhibition activities of pomegranate fruit peel methanolic extract. BMC Complement. Altern. Med. 2012;12(1):200.

Hunot S, Brugg B, Ricard D, Michel PP, Muriel MP, Ruberg M, Faucheux BA, Agid Y, Hirsch EC. Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with parkinson disease. Proc Natl Acad Sci U S A. 1997;94(14):7531–7536.

Neuhofer H, Witte L, Gorunovic M, Czygan FC. Alkaloids in the bark of Punica granatum L. (Pomegranate) from Yugoslavia. Pharmazie. 1993;48(5):389–391.

Medjakovic S, Jungbauer A. Pomegranate: A fruit that ameliorates metabolic syndrome. Food Funct. 2013;4(1):19–39.

Naveen S, Mahadevappa Siddalingaswamy DS, Khanum F. Anti-depressive effect of polyphenols and omega-3 fatty acid from pomegranate peel and flax seed in mice exposed to chronic mild stress. Psychiatry Clin. Neurosci. 2013;67(7):501–508.

Maher P, Dargusch R, Bodai L, Gerard PE, Purcell JM, Marsh JL. ERK activation by the polyphenols fisetin and resveratrol provides neuroprotection in multiple models of Huntington's disease. Hum Mol Genet. 2011; 20(2):261–270.

Freedland SJ, Carducci M, Kroeger N, Partin A, Rao JY, Jin Y, Kerkoutian S, Wu H, Li Y, Creel P, Mundy K, Gurganus R, Fedor H, King SA, Zhang Y, Heber D, Pantuck AJ. A double-blind, randomized, neoadjuvant study of the tissue effects of POMx pills in men with prostate cancer before radical prostatectomy. Cancer Prev Res (Phila). 2013;6(10):1120–7.

Klempner SJ, Bubley G. Complementary and alternative medicines in prostate cancer: from bench to bedside? Oncologist. 2012;17(6):830–837.

Aviram M, Dornfeld L. Pomegranate juice consumption inhibits serum angiotensin converting enzyme activity and reduces systolic blood pressure. Atherosclerosis. 2001; 158(1):195–198.

Lee DW, Andersen JK. Iron elevations in the aging Parkinsonian brain: A consequence of impaired iron homeostasis? Journal of Neurochemistry. 2010;112(2):332-9.

Riederer P, Sofic E, Rausch WD, Schmidt B, Reynolds GP, Jellinger K, Youdim MB. Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains. Journal of Neurochemistry. 1989;52(2):515-20.

Blum D, Torch S, Lambeng N, Nissou M-France, Benabid A Louis, Sadoul R, Verna J-Marc. Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: Contribution to the apoptotic theory in Parkinson's disease. Progress in Neurobiology. 2001;65(2):135-172.

Mondragón-Rodríguez S, Perry G, Zhu X, Boehm J. Amyloid Beta and tau proteins as therapeutic targets for Alzheimer’s disease treatment: rethinking the current strategy. Int. J. Alzheimers. Dis. 2012;630182.

Chinta SJ, Kumar MJ, Hsu M, Rajagopalan S, Kaur D, Rane A, Nicholls DG, Choi J, Andersen JK. Inducible alterations of glutathione levels in adult dopaminergic midbrain neurons result in nigrostriatal degeneration. J Neurosci. 2007;27(51):13997–14006.

Inden M, Kitamura Y, Takahashi K, Takata K, Ito N, Niwa R, Funayama R, Nishimura K, Taniguchi T, Honda T, Taira T, Ariga H. Protection against dopaminergic neuro-degeneration in Parkinson’s disease-model animals by a modulator of the oxidized form of DJ-1, a wild-type of familial Parkinson's disease-linked PARK7. J. Pharmacol. Sci. 2011;117(3):189–203.

Hu LF, Lu M, Tiong CX, Dawe GS, Hu G, Bian JS. Neuroprotective effects of hydrogen sulfide on Parkinson's disease rat models. Aging Cell. 2010;9(2):135–146.

Cadet JL, Brannock C. Free radicals and the pathobiology of brain dopamine systems. Neurochem Int. 1998;32(2):117–131.

Wu H, Tzeng N, Qian LS, Hu X, Chen S, Rawls S, Flood P, Hong J, Lu R. Novel neuroprotective mechanisms of memantine: Increase in neurotrophic factor release from astroglia and anti-inflammation by preventing microglial activation. Neuropsycho Pharmaco-logy. 2009;34(10):2344–2357.

Mochizuki H, Goto K, Mori H, Mizuno Y. Histochemical detection of apoptosis in Parkinson's disease. Journal of Neurological Sciences. 1996;137(2):120-123.

Rosenblat M, Aviram M. Pomegranate juice protects macrophages from triglyceride accumulation: Inhibitory effect on DGAT1 activity and on triglyceride biosynthesis. Ann. Nutr. Metab. 2011;58(1):1–9.

Clarke PG. Developmental cell death: morphological diversity and multiple mechanisms. Anatomy and Embryology. 1990; 181(3):195-213.

Lassmann H, Bancher C, Breitschopf H, Wegiel J, Bobinski M, Jellinger K, Wisniewski HM. Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ. Acta Neuropathol. 1995;89(1):35–41.

Charriaut-Marlangue C, Ben-Ari Y. A cautionary note on the use of the TUNEL stain to determine apoptosis. Neuroreport. 1995;7 (1):61-64

Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.Journal of Cell Biology. 1992; 119(3):493–501.

Calne DB, Chu NS, Huang CC, Lu CS, Olanow W. Manganism and idiopathic parkinsonism: Similarities and differences. Neurology. 1994;44(9):1583-1586.

Beal MF. Mitochondria take center stage in aging and neurodegeneration. Ann Neurol. 2005;58(4):495– 505.

Betarbet R, Sherer TB, Greenamyre JT. Animal models of Parkinson’s disease. Bioessays. 2002;24(4):308–318.

Calín-sánchez Á, Figiel A, Lech K, Carbonell-barrachina ÁA. Chemical composition, antioxidant capacity and sensory quality of pomegranate (Punica granatum L.) arils and rind as affected by drying method. Food Bioprocess Technol. 2013;6:1644–1654.

McGeer PL, Itagaki S, Boyes BE, Mc Geer EG. Reactive microglia are positive for HLA-DR in the SN of Parkinson's and Alzheimer's disease brains. Neurology. 1998;38(8):1285–1291.

Boka G, Anglade P, Wallach D, Javoy-Agid F, Agid Y, Hirsch EC. Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease. Neurosci Lett. 1994;172(1-2):151–154.

Addabbo F, Montagnani M, Goligorsky SM. Mitochondria and reactive oxygen species. Hypertensionaha. 2009;53:885-892.

Kim GH, Kim JE, Rhie SJ, Yoon S. The role of oxidative stress in neurodegenerative diseases. Exp Neurobiol. 2015;24(4):325-340.

Lin M, Beal M. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature. 2006;443(7113):787–795.

LiS Y, Jia YH, Sun WG, Tang Y, An GS, Ni JH, Jia HT.Stabilization of mitochondrial function by tetramethylpyrazine protects against kainate-induced oxidative lesions in the rat hippocampus. Free Radical Biology and Medicine. 2010;48(4):597-608.

Liang LP, Huang J, Fulton R, Day BJ, Patel M. An orally active catalytic metalloporphyrin protects against 1-methyl-4phenyl-1,2,3,6-tetrahydropyridine neurotoxicity in vivo. J Neurosci. 2007;27(16): 4326–4333.

Kerr J, Wyllie A, Currie A. Apoptosis: A basic biological phenomenon with wide ranging implications in tissue kinetics. British Journal of Cancer. 1972;26(4):239–257.

Ambani LM, Van Woert MH, Murphy S. Brain peroxidase and catalase in parkinson disease. Arch Neurol. 1975;32(2):114–118.

Granato D, Karnopp AR, van Ruth SM. Characterization and comparison of phenolic composition, antioxidant capacity and instrumental taste profile of juices from different botanical origins. J. Sci. Food Agric. 2014;95(10):1997-2006.

Ramassamy C. Emerging role of polyphenolic compounds in the treatment of neuro-degenerative diseases: a review of their intracellular targets. Eur J Pharmacol. 2006;545 (1):51–64.

Essa MM, Vijayan RK, Castellano-Gonzalez G, Memon MA, Braidy N, Guillemin GJ. Neuroprotective effect of natural products against Alzheimer's disease. Neurochemical Research. 2012;37(9):1829–1842.